“DENDRON-02: Efficacy and Safety of Combined Dendritic Cell Vaccine CaTeVac Immunotherapy and Standard Chemotherapy in Patients With CNS Glial Tumors. First Results”. Voprosy Onkologii, vol. 72, no. 2, May 2026, p. OF-2504, https://doi.org/10.37469/0507-3758-2026-72-2-OF-2504.